We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EC Panel Recommends Phased Approach to Risk Evaluation of Nanomaterials
EC Panel Recommends Phased Approach to Risk Evaluation of Nanomaterials
Manufacturers of medical devices that contain nanomaterials should use a phased approach to evaluate risk in order to avoid unnecessary testing, an expert committee of the European Commission recommends.